Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, building on our heritage in diabetes. We do this by advancing scientific progress, increasing access to our medicines, and working to prevent — and ultimately cure — diseases. Novo Nordisk markets its products in around 170 countries.